Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
11.94 USD | +0.89% |
|
-2.17% | -11.07% |
05:50pm | Global markets live: Tesla, Citigroup, BP, Novo Nordisk, JPMorgan... | ![]() |
05:34pm | BASF: to close two German GA production sites | CF |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company has attractive valuation levels with a low EV/sales ratio compared with its peers.
- This company will be of major interest to investors in search of a high dividend stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The company is highly valued given the cash flows generated by its activity.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
Ratings chart - Surperformance
Sector: Diversified Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-11.07% | 42.2B | - | ||
+13.49% | 82.75B | B | ||
+4.86% | 33.27B | C | ||
+16.44% | 19.26B | B | ||
+9.70% | 11.3B | A- | ||
-23.89% | 9.92B | B | ||
-12.56% | 9.33B | - | ||
+3.13% | 9.01B | A- | ||
-3.55% | 8.52B | C- | ||
+6.97% | 8.11B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BAS Stock
- BASFY Stock
- Ratings BASF SE